SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors debate the potential for a strategic buyout or major partnership, driven by ongoing interest in its Matrix-M platform and upcoming catalysts surrounding Sanofis COVID/Flu combination vaccine. Despite active community discussion regarding institutional buying and long-term potential, the stock continues to face downward pressure and high short interest, with many shareholders expressing frustration over the lack of direct communication from management.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly await pivotal Phase 3 IZAR trial data for its inflammatory disease treatment, sonelokimab. The community is focused on the potential for 'best-in-class' efficacy results to catalyze a significant re-rating of the company and trigger a potential acquisition, though managements timeline has created tension among shareholders.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending due to heightened volatility and a technical pullback after a strong rally, with the community actively debating whether this is a healthy retest or a sign of overvaluation. Traders are focusing on potential support levels following intense options activity, while long-term investors continue to track the company's critical role in AI infrastructure and hyperscaler capital spending.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as market participants closely monitor GameStop's unsolicited acquisition pursuit, fueling significant community debate over the potential for hostile takeover tactics and strategic restructuring. Investors are actively discussing the implications of GameStop's stake, the company's financial capacity to fund the deal, and the broader impact on eBay's leadership and operational future.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

ProShares Ultra Bloomberg Crude Oil (UCO) is trending as traders react to extreme price volatility fueled by conflicting headlines surrounding potential U.S.-Iran negotiations and the status of the Strait of Hormuz. The community remains deeply divided, with some betting on a sustained supply-side price recovery while others anticipate a sharp correction driven by potential de-escalation and global production increases.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing significant market volatility driven by a combination of positive Q2 earnings, which saw a revenue beat and raised guidance, and ongoing investor sensitivity to health-related headlines. The community remains sharply divided, with bulls pointing to robust long-term expansion and operational resilience, while bears focus on supply chain concerns and what they perceive as an unsustainable valuation.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is seeing heightened investor activity ahead of the upcoming Phase 2 clinical trial readout for ABCL635, a key asset for treating menopause-related symptoms. The community is actively debating the stock's potential for a significant re-rating, focusing on how this trial could validate the company's AI-driven antibody discovery platform and its broader pipeline.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is trending as investors weigh its role as a decentralized AI infrastructure leader against recent volatility and governance concerns surrounding specific subnets. The community remains focused on the project's long-term utility in the evolving AI economy, actively debating its potential as a sovereign alternative to centralized tech giants despite ongoing price fluctuations.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is currently at the center of heated debates as market participants react to the repeated delays of the Clarity Act, fueling intense speculation over whether institutional utility will ultimately drive the price or if the asset has lost its momentum. The community remains deeply divided, with some investors aggressively accumulating during this price stagnation in anticipation of future global adoption, while others are vocalizing deep frustration and skepticism regarding the project's long-term viability.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio shares are under active discussion following a Q2 earnings report that showed strong year-over-year revenue growth for Anktiva, leading investors to debate the stock's future amid persistent heavy short interest and speculation regarding potential global partnerships or a future buyout. The community remains focused on the company's manufacturing expansion at Dunkirk and upcoming regulatory milestones, with many long-term holders dismissing current price volatility as institutional accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
